Health & Biotech
Health & Biotech
Bioxyne subsidiary unveils platform for transparent pricing in Australia’s B2B medical cannabis market
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as Morgans upgrades Sigma on proposed Chemist Warehouse merger
Health & Biotech
ASX Health Stocks: Mesoblast rockets 20pc after being granted Rare Pediatric Disease Designation by FDA
Health & Biotech
The next Neuren? These ASX biotech stocks have pending FDA catalysts in 2024
Health & Biotech
ASX Health Stocks: Amplia gets FDA green light to commence trial; Recce study meets all primary endpoints
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
Health & Biotech
ASX Health Stocks: Imugene gains on positive early signs from Phase 1 trial
Health & Biotech
PharmAust partners with US-based Berry Consultants for Phase 2/3 study
Health & Biotech
ASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, Travelan
Health & Biotech
ScoPo’s Powerplays: ASX health stocks feeling the love as Avita Medical kicks off 2024 strongly
Health & Biotech
ASX Health Stocks: Lumos, Singular, and Imricor all jump today after deals and approvals
Health & Biotech
Weed Week: Blow to cannabis as Thailand backpedals on weed law; and recent ASX pot stock winners
Health & Biotech
ASX Health Stocks: Emyria surges 19pc after granting of ‘Authorised Prescriber’ status by TGA
Health & Biotech
Weed Week: Cannabis stocks down almost 20% in 2023 but ECS Botanics showing resilience
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.